Product Program year 2025 Source: CMS Open Payments

Harmonic

Device Energy

PDI 10705036002093

Open in the dashboard

General payments

$3,636,825

9,785 payments

Research payments

$813,119

85 payments

Through program year 2025, $3,636,825 in general payments and $813,119 in research payments were reported against Harmonic (Energy).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

10 rows
Year Kind Amount Payments
2025 General $1,032,469 2,519
2025 Research $130,545 19
2024 General $846,741 2,465
2024 Research $61,593 9
2023 General $549,605 1,619
2023 Research $399,121 30
2022 General $699,487 1,425
2022 Research $165,582 20
2021 General $508,522 1,757
2021 Research $56,279 7

Breakdown

Who paid General payments · program years 2021–2025
  1. Medical Device Business Services, Inc. $1,726,644 1,524 payments
  2. Ethicon US, LLC $1,473,769 7,923 payments
  3. Ethicon Inc. $305,866 163 payments
  4. Ethicon Endo-Surgery Inc. $110,902 49 payments
  5. DePuy Synthes Sales Inc. $9,671 10 payments
  6. Johnson and Johnson International $7,816 105 payments
  7. DePuy Synthes Products, Inc. $1,300 1 payment
  8. Johnson & Johnson Surgical Vision, Inc. $588 5 payments
  9. Johnson & Johnson Health Care Systems Inc. $270 5 payments
Top recipients General payments · program year 2025
  1. Dennis Kraus Otolaryngology · New York, NY $124,510 12% · 57 payments
  2. David Longcope Colon & Rectal Surgery · Denver, CO $74,803 7% · 63 payments
  3. Kurian Thott Obstetrics & Gynecology · Stafford, VA $57,914 6% · 30 payments
  4. Diego Marines Copado Colon & Rectal Surgery · Houston, TX $51,647 5% · 37 payments
  5. John Lipham Surgery · Los Angeles, CA $45,530 4% · 7 payments

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2025
  1. Surgery $252,201 25% · 496 practitioners
  2. Otolaryngology $205,145 21% · 63 practitioners
  3. Colon & Rectal Surgery $205,081 21% · 68 practitioners
  4. Obstetrics & Gynecology $129,137 13% · 213 practitioners
  5. Thoracic Surgery (Cardiothoracic Vascular Surgery) $50,010 5% · 57 practitioners

The top 5 of 82 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2025
  1. New York $190,151 18% · 82 recipients
  2. California $185,914 18% · 162 recipients
  3. Texas $136,654 13% · 130 recipients
  4. Florida $82,930 8% · 123 recipients
  5. Colorado $76,282 7% · 7 recipients

The top 5 of 50 states; each share is of general payments naming this product in 2025 where a state was reported.

The top 25 states, free in the app

9,785 general · 85 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2025

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record